How Roche Maximizes the Impact of Patient Insights in Early Development for a Blueprint to De-Risk Molecule Development
Roche's Patient Voice Partner, Strategy, Portfolio & Operations presents their dedicated effort to drive patient inclusivity in early-stage development across R&D.
Summary:
In this podcast, Roche's Patient Voice Partner, Strategy, Portfolio & Operations, presents their dedicated effort to drive patient inclusivity in early-stage development across R&D. Specifically, this presentation covers:
- The process of embedding patient inclusivity in early development
- How to integrate patient insights early and systematically starting with early development
- How to engage patient communities to shape early clinical trials (Phase I and Phase II) to reduce patient burden, improve patient experience and bring medicines to market that are valued by the patient community
Related Podcasts
View All
How Roche Maximizes the Impact of Patient Insights in Early Development for a Blueprint to De-Risk Molecule Development
Working with Patient Organizations to Use Patient Insights Meaningfully throughout Medicine & Disease Lifecycles
Simplicity in Technology Delivery for Clinical Trials
